FRIDAY, May 11 (HealthDay News) — One failed kidney transplant doesn't mean a second transplant is likely to fail, according to a new study that found similar kidney survival, rejection and infection rates in people who undergo repeat transplants …
Man sues UCSD over cancerous kidney transplant
A San Diego County man who received a cancerous kidney during a transplant goes to court next week against the doctor who performed the operation.
UPMC-led Study Finds Improvements in Pacemaker Lead Placement Get Better … – HealthCanal.com
UPMC-led Study Finds Improvements in Pacemaker Lead Placement Get Better …HealthCanal.comNearly 6 million people in the US suffer from heart failure, which occurs when the heart cannot pump enough blood and oxygen to support other organs. Some patien…
Dead UK girl saves 8 lives through organ donation – IBNLive.com
IBNLive.comDead UK girl saves 8 lives through organ donationIBNLive.com"She had spoken of her wish to be an organ donor when she died. It is so sad and we all miss her terribly," they said. In addition two adults aged 19 and 24 received her k…
Scientific discovery sheds light on a genetic cause of heart failure – HealthCanal.com
Scientific discovery sheds light on a genetic cause of heart failureHealthCanal.comHOUSTON – – Researchers at Baylor College of Medicine have shown how a finely tuned genetic mechanism protects mice from the onset of heart failure. In a study in the cu…
Mom wakes up to new heart after surprise transplant
A Kingsport woman in desperate need of a heart transplant received the gift of life and didn't even know it.
On 'brain death,' a response to a rebuttal – Catholic Culture
Catholic CultureOn 'brain death,' a response to a rebuttalCatholic CultureBy Phil Lawler (bio – articles – send a comment) | May 11, 2012 5:17 PM Last month, when I questioned whether “brain death” is a valid justification for removing vita…
Isotechnika Reports First Quarter 2012 Financial Results
EDMONTON, Alberta — Isotechnika Pharma Inc. today announced financial results for the three months ended March 31, 2012.
New maintenance therapy for multiple myeloma looks promising, study suggests
Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing damage to bones as well as predisposing patients to anemia, infection and kidney failure. Unfortunately, multiple myeloma continues to progress …
Standard Review for Biogen's BG-12 – Analyst Blog – NASDAQ
Standard Review for Biogen's BG-12 – Analyst BlogNASDAQMeanwhile, Biogen and partner Abbott ( ABT ) moved their MS candidate, daclizumab, into a two-year phase III study (DECIDE) in July 2010. Daclizumab is being evaluated as a once-monthly or bi-w…